Perspective Therapeutics Inc CATX Q1 2026 Earnings EPS Beat by 17 as PreRevenue Biotech Advances Radiopharmaceutical Pipeline Intellia Therapeutics NTLA Q1 2026 Earnings NarrowerThanExpected Loss Fuels Market Optimism Bioventus BVS Q1 2026 Earnings EPS Surges Past Expectations Despite Revenue Opacity FAST Q1 2026 Earnings EPS Misses Estimates as Industrial Demand Weighs Greenidge Generation Holdings 850 Senior Notes GREEL Q1 2025 Earnings Narrowed Loss Exceeds Expectations as Stock Reacts Cautiously AFL Q1 2026 Earnings EPS Misses Estimates Stock Holds Steady